摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4aR,8aR)-2,2-dimethyldecahydroquinoxaline | 1365793-78-7

中文名称
——
中文别名
——
英文名称
(4aR,8aR)-2,2-dimethyldecahydroquinoxaline
英文别名
(4aR,8aR)-3,3-dimethyl-2,4,4a,5,6,7,8,8a-octahydro-1H-quinoxaline
(4aR,8aR)-2,2-dimethyldecahydroquinoxaline化学式
CAS
1365793-78-7
化学式
C10H20N2
mdl
——
分子量
168.282
InChiKey
FDRMAGYYKBUJLO-RKDXNWHRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    24.1
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (4aR,8aR)-2,2-dimethyldecahydroquinoxaline4-bromo-1-difluoromethoxy-2-difluoromethylbenzene 在 palladium diacetate 、 sodium t-butanolate 、 tri tert-butylphosphoniumtetrafluoroborate 、 盐酸 作用下, 以 甲苯乙醇乙酸乙酯 为溶剂, 反应 4.0h, 以44%的产率得到(4aR,8aR)-1-(4-difluoromethoxy-3-(difluoromethyl)phenyl)-3,3-dimethyldecahydroquinoxaline dihydrochloride
    参考文献:
    名称:
    [EN] DECAHYDROQUINOXALINE DERIVATIVES AND ANALOGS THEREOF
    [FR] DÉRIVÉS DE DÉCAHYDROQUINOXALINE ET LEURS ANALOGUES
    摘要:
    通用式(1)表示的杂环化合物或其盐:其中m,l和n分别表示1或2的整数;X表示-O-或-CH2-;R1表示氢,较低的烷基基团,羟基较低的烷基基团,保护基或三较低烷氧基较低的烷基基团;R2和R3,相同或不同,各自独立地表示氢或较低的烷基基团;或R2和R3结合形成环-C3-C8烷基基团;R4表示芳香基团或杂环基团,其中芳香基团或杂环基团可能具有一个或多个任意取代基。
    公开号:
    WO2013137479A1
点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS CYCLIQUES SUBSTITUÉS ET PROCÉDÉS D'UTILISATION
    申请人:XI NING
    公开号:WO2013138210A1
    公开(公告)日:2013-09-19
    The present invention provides novel substituted cyclic compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
    本发明提供了新颖的取代环化合物,药用可接受的盐及其制剂,用于调节蛋白酪氨酸激酶活性,并调节细胞活动,如增殖、分化、凋亡、迁移和侵袭。该发明还提供了包括这些化合物的药用可接受的组合物,以及在治疗哺乳动物,特别是人类的增生性疾病中使用这些组合物的方法。
  • [EN] HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE.<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LE TRAITEMENT OU LA PRÉVENTION DE TROUBLES PROVOQUÉS PAR UNE NEUROTRANSMISSION RÉDUITE DE LA SÉROTONINE, DE LA NORÉPINEPHRINE OU DE LA DOPAMINE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2012036253A1
    公开(公告)日:2012-03-22
    A heterocyclic compound represented by the general formula (1) or a salt thereof: wherein m, l, and n respectively represent an integer of 1 or 2; X represents -O- or -CH2-; R1 represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R2 and R3, which are the same or different, each independently represent hydrogen or a lower alkyl group; or R2 and R3 are bonded to form a cyclo-C3-C8 alkyl group; and R4 represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).
    通用式(1)表示的杂环化合物或其盐:其中m、l和n分别表示1或2的整数;X表示-O-或-CH2-;R1表示氢、较低的烷基基团、羟基较低的烷基基团、保护基或三较低烷氧基较低的烷基基团;R2和R3,相同或不同,各自独立地表示氢或较低的烷基基团;或R2和R3结合形成环-C3-C8烷基基团;R4表示芳香基团或杂环基团,其中芳香基团或杂环基团可能具有一个或多个任意取代基。
  • HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE
    申请人:Ito Nobuaki
    公开号:US20130261081A1
    公开(公告)日:2013-10-03
    A heterocyclic compound represented by the general formula (1) or a salt thereof: wherein m, l, and n respectively represent an integer of 1 or 2; X represents —O— or —CH 2 —; R 1 represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R 2 and R 3 , which are the same or different, each independently represent hydrogen or a lower alkyl group; or R 2 and R 3 are bonded to form a cyclo-C3-C8 alkyl group; and R 4 represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).
    一种由通式(1)表示的杂环化合物或其盐: 其中,m、l和n分别表示1或2的整数;X表示-O-或-CH2-;R1表示氢、低碳基、羟基-低碳基、保护基或三-低硅氧基-低碳基;R2和R3分别独立地表示氢或低碳基;或者R2和R3结合形成环状C3-C8烷基;R4表示芳基或杂环基,其中芳基或杂环基可能具有一个或多个任意取代基。
  • HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:US20160058757A1
    公开(公告)日:2016-03-03
    A heterocyclic compound represented by the general formula (1) or a salt thereof: wherein m, I, and n respectively represent an integer of 1 or 2; X represents —O— or —CH 2 —; R 1 represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R 2 and R 3 , which are the same or different, each independently represent hydrogen or a lower alkyl group; or R 2 and R 3 are bonded to form a cyclo-C3-C8 alkyl group; and R 4 represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).
    一种由通式(1)表示的杂环化合物或其盐: 其中,m、I和n分别表示1或2的整数;X表示—O—或—CH2—;R1表示氢、低级烷基、羟基-低级烷基、保护基或三-低级烷基硅氧-低级烷基;R2和R3分别独立地表示氢或低级烷基;或R2和R3结合形成环状C3-C8烷基;且R4表示芳香基或杂环基,其中芳香或杂环基可以具有一个或多个任意取代基。
  • Method for treating depression and/or depression status with substituted quinoxaline compounds
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:US10064879B2
    公开(公告)日:2018-09-04
    A heterocyclic compound represented by the general formula (1) or a salt thereof: wherein m, l, and n respectively represent an integer of 1 or 2; X represents —O— or —CH2—; R1 represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R2 and R3, which are the same or different, each independently represent hydrogen or a lower alkyl group; or R2 and R3 are bonded to form a cyclo-C3-C8 alkyl group; and R4 represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).
    由通式(1)代表的杂环化合物或其盐: 其中 m、l 和 n 分别代表 1 或 2 的整数;X 代表 -O- 或 -CH2-; R1 代表氢、低级烷基、羟基-低级烷基、保护基团或三低级烷基硅氧基-低级烷基; R2 和 R3(相同或不同)各自独立地代表氢或低级烷基;或 R2 和 R3 键合形成环-C3-C8 烷基;以及 R4 代表芳香基团或杂环基团,其中 芳香基团或杂环基团可具有一个或多个任意取代基。
查看更多